Business
MJardin Announces Phase 1 Construction Completion of their Manitoba Cultivation Facility, Submits Evidence of Readiness Package to Health Canada
MJardin Announces Phase 1 Construction Completion of their Manitoba Cultivation Facility, Submits Evidence of Readiness Package to Health Canada.
About this update from Mjardin Group Inc
[{"type":"text","content":"\nTORONTO and DENVER, Aug. 12, 2019 (GLOBE NEWSWIRE) -- MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), a leader in premium cannabis production, announced today that it has submitted its Evidence of Readiness package to Health Canada and completed construction on Phase 1 of “WARMAN”, a retrofitted indoor cultivation facility located in Winnipeg, Manitoba and the largest in the Company’s portfolio.\n “Reaching this Health Canada milestone at our flagship Winnipeg facility is a significant achievement for our company,” noted Eric Gattoni, SVP, Operations of MJardin Group. “We look forward to cultivation at this facility as well as releasing our plans for Phase 2 of the project.” “WARMAN” is MJardin’s fourth Canadian cannabis cultivation facility to submit an Evidence of Readiness package to Health Canada. The facility joins the Company’s portfolio which consists of two facilities in Ontario and one in Nova Scotia. The Company expects to receive its cultivation license for the Warman facility in the fourth quarter of 2019. About MJardin GroupMJardin is a cannabis management platform with extensive experience in cultivation, processing, distribution and retail. For over 10 years, MJardin has refined cultivation methodologies, developed state of the art facilities and implemented vertical integration for and on behalf of license owners. MJardin is based in Denver, Colorado and Toronto, Canada. For more information, please visit www.mjardin.com The CSE has not in any way passed upon the merits of and has neither approved nor disapproved the contents of this news release. This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Forward-Looking Information This news release contains forward-looking information based on current expectations. Statements ...